RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 Updates in ICD and CRT Technology
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 28 suppl 2
SP 11
OP 12
DO 10.1177/1559897715612451
UL http://mdc.sagepub.com/content/15/28_suppl_2/11.abstract
AB The development of leadless and subcutaneous implantable cardiac defibrillators and cardiac resynchronization therapy may improve safety of these therapies by utilizing less invasive procedures and reducing infection rates. In addition, wearable cardiac defibrillators can provide protection for certain patient populations, including those who are awaiting implantation or require implantable cardiac defibrillator removal.